Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression.
Stanley I GutiontovKevin S ChoeJonathan L MillerStanley L LiauwPublished in: Cancer medicine (2020)
AP/AC was associated with improved FFBF. Low platelet count was associated with inferior FFBF and FFDM after prostate radiotherapy. This association was tempered when antiplatelet and anticoagulant therapy was administered.
Keyphrases
- prostate cancer
- antiplatelet therapy
- early stage
- percutaneous coronary intervention
- atrial fibrillation
- acute coronary syndrome
- venous thromboembolism
- locally advanced
- radical prostatectomy
- radiation induced
- radiation therapy
- peripheral blood
- transcription factor
- squamous cell carcinoma
- stem cells
- benign prostatic hyperplasia
- mesenchymal stem cells
- bone marrow